Atea Pharmaceuticals Inc (AVIR)
3.705
+0.02
(+0.41%)
USD |
NASDAQ |
Apr 26, 16:00
3.705
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Total Liabilities (Quarterly): 39.78M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.78M |
| September 30, 2023 | 26.34M |
| June 30, 2023 | 23.68M |
| March 31, 2023 | 19.95M |
| December 31, 2022 | 26.14M |
| September 30, 2022 | 23.39M |
| June 30, 2022 | 33.88M |
| March 31, 2022 | 37.30M |
| Date | Value |
|---|---|
| December 31, 2021 | 62.82M |
| September 30, 2021 | 262.05M |
| June 30, 2021 | 273.68M |
| March 31, 2021 | 254.39M |
| December 31, 2020 | 315.83M |
| September 30, 2020 | 186.62M |
| June 30, 2020 | 7.127M |
| December 31, 2019 | 71.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.127M
Minimum
Jun 2020
315.83M
Maximum
Dec 2020
104.04M
Average
38.54M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 594.97M |
| Shareholders Equity (Quarterly) | 555.19M |